000 01233 a2200349 4500
005 20250516200156.0
264 0 _c20140926
008 201409s 0 0 eng d
022 _a2046-4053
024 7 _a10.1186/2046-4053-3-14
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFeys, Frederik
245 0 0 _aDo randomized clinical trials with inadequate blinding report enhanced placebo effects for intervention groups and nocebo effects for placebo groups?
_h[electronic resource]
260 _bSystematic reviews
_cFeb 2014
300 _a14 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aDouble-Blind Method
650 0 4 _aErectile Dysfunction
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aNocebo Effect
650 0 4 _aPhosphodiesterase 5 Inhibitors
_xtherapeutic use
650 0 4 _aPlacebo Effect
650 0 4 _aPlacebos
650 0 4 _aRandom Allocation
650 0 4 _aRandomized Controlled Trials as Topic
_xmethods
700 1 _aBekkering, Geertruida E
700 1 _aSingh, Kavita
700 1 _aDevroey, Dirk
773 0 _tSystematic reviews
_gvol. 3
_gp. 14
856 4 0 _uhttps://doi.org/10.1186/2046-4053-3-14
_zAvailable from publisher's website
999 _c23572877
_d23572877